The HPRA today published its annual report of key activities and performance highlights for 2014. The report, which is the first to feature the organisation’s new name and brand identity, highlights a year of significant activity for the national regulator of health products. There was a continued focus on tackling the issue of falsified and illegal prescription medicines as well as on drawing attention to the associated dangers. The list of interchangeable medicines, which facilitates generic substitution by pharmacists and is linked to the HSE’s reference pricing system, was significantly expanded during the year.
Download:
- HPRA Press Release
- Annual Report 2014
- Tuarascáil Bhliantúil 2014